Pharming is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development.
Our key strengths include the following:
- Sales growth of our commercialized asset.
- Proven rare-disease commercialization capabilities.
- Internal pipeline of product candidates.
- Transgenic Production Platform Technology.
- Data exclusivity, know-how and intellectual property.
Darwinweg 24, 2333 Leiden, Zuid-Holland – Netherlands
Jan. 1, 2000Stock exchange(s)